Response of atrial flutter to overdrive atrial pacing and intravenous disopyramide phosphate, singly and in combination.

J Camm, D Ward, R Spurrell

Ten patients who suffered spontaneous paroxysms of atrial flutter were investigated by electrophysiological techniques. Two had overt Wolff-Parkinson-White syndrome; three Lown-Ganong-Levine syndrome; and one a concealed accessory atrioventricular connection. Atrial flutter was initiated, at study, by right atrial pacing and electrograms from the right atrium and coronary sinus were observed for at least five minutes to ensure stable flutter in both atria. Atrial flutter was terminated by 2.5 s or 5 s bursts of atrial pacing at rates 10, 50, or 100 beats/min faster than the intrinsic flutter rate in only two patients. Atrial flutter, which was reinitiated in two patients, was then treated with intravenous disopyramide phosphate, 2 mg/kg body weight, infused over five minutes. In all 10 patients the atrial rate slowed from a mean of 310 +/- 39 beats/min to 217 +/- 27 beats/min and atrial flutter terminated in one case. Though the mean ventricular rate fell from 161 +/- 52 beats/min to 156 +/- 45 beats/min the atrioventricular conduction ratio fell from 2.17 +/- 0.86 to 1.55 +/- 0.59 and four patients were left with symptomatically significant increases of ventricular rate. In seven of nine patients overdrive atrial pacing, repeated after disopryamide, resulted in the conversion of atrial flutter to sinus rhythm. In this study, overdrive atrial pacing and intravenous disopyramide, singly and in combination, terminated atrial flutter in nine of the 10 patients and it is suggested that this method may provide an effective alternative to direct current cardioversion.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Everett, T. H. IV, Akar, J. G., Kok, L.-C., Moorman, J. R., Haines, D. E. (2002). Use of global atrial fibrillation organization to optimize the success of burst pace termination. J Am Coll Cardiol 40: 1831-1840 [Abstract] [Full Text]  
• Riva, S., Tondo, C., Carbucicchio, C., Galimberti, P., Fassini, G., Della Bella, P. (1999). Incidence and clinical significance of transformation of atrial fibrillation to atrial flutter in patients undergoing long-term antiarrhythmic drug treatment. Europace 1: 242-247 [Abstract]  
• WALDO, A. L., OLSHANSKY, B., HENTHORN, R. W. (1987). Use of Implanted Antitachycardia Pacemakers to Treat Paroxysmal Atrial Flutter. ANN INTERN MED 107: 247-248 [Abstract]  
• MORADY, F., SCHEINMAN, M. M., DESAI, J. (1982). Drugs Five Years Later: Disopyramide. ANN INTERN MED 96: 337-343 [Abstract]